Generic lenacapavir HIV prevention shot wins US FDA approval - IOL
Direct Source Verification:
This story is aggregated from IOL News (iol.co.za). Full reporting rights and copyright belong to the primary publisher.
The United States' FDA has approved the generic version of twice-yearly HIV prevention shot.
The United States' FDA has approved the generic version of twice-yearly HIV prevention shot.
The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, lenacapavir, bringing the breakthrough drug closer to market in low-income countries.
The approval was announced by Dr. Reddy's Laboratories, the Indian maker of the generic version of lenacapavir, and by Unitaid, a global health initiative.
Original Source
https://iol.co.za/news/world/2026-11-02-generic-lenacapavir-hiv-prevention-shot-wins-us-fda-approval/
